So I really depend on my medication." Sir Peter Luff, a former defence minister and MP for Mid Worcestershire, explained how ...
Inhibikase Therapeutics is pausing work on its experimental Parkinson’s disease drug risvodetinib and seeking “strategic ...
Researchers from the Cleveland Clinic Genome Center have successfully applied advanced artificial intelligence (AI) genetics ...
Kevin Hill, 65, used to suffer sleepless nights due to his harrowing Parkinson's disease symptoms. Now, he forgets about his ...
Researchers have discovered how a cell surface protein called Aplp1 can play a role in spreading material responsible for ...
Inhibikase Therapeutics announced disappointing results from a Phase 2 trial for its Parkinson’s disease drug, risvodetinib, and will now pause its development.
“imaging has been used to confirm that the biology of the brain in those suffering with Parkinson’s disease is changed by intense exercise.” Another newer treatment is focused ultrasound. Clinical ...
In a significant advancement for Parkinson’s Disease (PD) therapy, researchers have developed a targeted nano formulation ...
Scientists from the Institute of Nano Science and Technology (INST) Mohali, an autonomous institute of the Department of ...
Innovative treatment for Parkinson's disease: microscopic particles combined with light therapy offer a non-surgical solution ...
Researchers in China discovered that an injection of nanoparticles into the brain could reverse the symptoms of Parkinson's Disease.